The effects of compounds on KRAS transcription in colon cancer cells (HCT116 and SW620) were evaluated by quantifying KRAS mRNA steady-state levels using Taqman real-time RT-PCR. The gene discussed is KRAS; the disease is malignant colon neoplasm.